Spire Wealth Management »

Nuvectis Pharma shares owned by Spire Wealth Management

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Spire Wealth Management from 13F filings

Historical chart of Spire Wealth Management investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Spire Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Spire Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3k 300 7.55

More positions owned by Spire Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S P 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for Spire Wealth Management

Top funds holding Nuvectis Pharma

Vanguard Group
BlackRock
Iridian Asset Management
Baldwin Brothers
Geode Capital Management
State Street Corporation
Northern Trust
Susquehanna International
Citadel Advisors
Oppenheimer & Co
Paul Kendrigan
Goldman Sachs Group
Renaissance Technologies
Charles Schwab Investment Management
Royal Bank of Canada

View all funds holding Nuvectis Pharma